Cystatin C in acute heart failure without advanced renal impairment

Hiroyuki Naruse1, Junnichi Ishii, Tomoko Kawai

  • 1Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan.

Insights

Cystatin C measurement improves early risk stratification in acute heart failure patients with mild renal impairment, outperforming the Modification of Diet in Renal Disease (MDRD) equation for predicting cardiac mortality.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Assessing renal function in acute heart failure (AHF) is crucial for risk stratification.
  • The prognostic value of cystatin C versus estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) equation in AHF patients with normal to moderate renal impairment remains understudied.
  • Improved detection of mild renal impairment may enhance risk stratification in these patients.

Purpose of the Study:

  • To investigate the prognostic value of cystatin C compared to eGFR (MDRD) in predicting cardiac mortality in AHF patients with preserved renal function.
  • To determine if cystatin C offers superior risk stratification compared to eGFR (MDRD) in this specific patient cohort.

Main Methods:

  • A cohort of 328 consecutive patients hospitalized for worsening chronic heart failure with eGFR (MDRD) ≥30 mL/min/1.73 m² were enrolled.
  • Cystatin C and creatinine levels were measured upon admission.
  • Patients were followed for a median of 915 days to ascertain cardiac deaths.

Main Results:

  • Cystatin C, but not eGFR (MDRD), was independently associated with cardiac mortality (P <.0001) in Cox regression analyses.
  • Kaplan-Meier and adjusted relative risk analyses indicated cystatin C better separated low-risk from high-risk patients.
  • Receiver-operating characteristic curve analyses demonstrated higher precision of cystatin C in predicting cardiac mortality.

Conclusions:

  • Cystatin C measurement may enhance early risk stratification in acute heart failure patients with normal to moderately impaired renal function.
  • Cystatin C appears to be a more precise predictor of cardiac mortality than eGFR (MDRD) in this population.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...